|
|
 |
SENSEX
|
 |
-452.60
|
-0.63%
|
71573.55
|
|
|
NIFTY
|
 |
-148.60
|
-0.68%
|
21562.20
|
|
|
Nasdaq
|
 |
13.77
|
0.09%
|
14524.07
|
|
|
Nikkei 225
|
 |
89.13
|
0.27%
|
33377.42
|
|
|
FTSE 100
|
 |
-33.50
|
-0.43%
|
7689.60
|
|
|
 |
|
|
|
|
|
YOU ARE ON
Equity
|
|
|
|
|
|
|
|
|
Industry : Pharmaceuticals & Drugs |
House : Lupin |
BSE Code |
500257
|
ISIN Demat |
INE326A01037
|
Book Value (Rs) |
423.36
|
|
NSE Code |
LUPIN
|
Dividend Yield % |
0.29
|
Market Cap (Rs) |
629420.66
|
|
TTM PE(x) |
53.12
|
TTM EPS(Rs) |
26.02
|
Face Value(Rs.) |
2
|
|
|
|
|
|
|
Incorporation Year
|
01-03 1983
|
Registered Office
|
Kalpataru Inspire, 3rd Floor,Off. Western Express Highway,Santacruz (East), Mumbai, Maharashtra-400055 .
|
ISINNO
|
INE326A01037
|
Phone
|
022 66402323
|
E-mail
|
info@lupin.com |
URL
|
www.lupin.com |
Industry
|
Pharmaceuticals & Drugs
|
Chairman
|
Manju D Gupta
|
Managing Director
|
Nilesh Gupta
|
Company Secretary
|
R V Satam
|
Listing
|
BSE,NSE,MCX
|
|
|
|
|
|
|
|
|
|
|
|